ROI Influencers: Health Care 2023
Fabian Gerlinghaus
Co-founder & CEO
Cellares
His company, which just raised $255 million in Series C funding, aims to open 118,000-square-foot facility in Bridgewater by end of 2024 that will produce game-changing cancer medication. It’s a huge get for the state.
